Benzinga | Mar 29, 2021 04:02PM EDT

Celldex Therapeutics Q4 EPS $(0.55) Up From $(0.64) YoY, Sales $3.80M Up From $887.00K YoY

Celldex Therapeutics (NASDAQ:CLDX) reported quarterly losses of $(0.55) per share. This is a 14.06 percent increase over losses of $(0.64) per share from the same period last year. The company reported $3.80 million in sales this quarter. This is a 328.41 percent increase over sales of $887.00 thousand the same period last year.